Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Visgeneer is a Taiwan-based biotechnology company specializing in the development and manufacturing of point-of-care testing (POCT) systems and biosensor technologies. The company's primary product lines include multi-functional monitoring systems for blood glucose, uric acid, cholesterol, and hemoglobin, marketed under the "eB" brand. Beyond medical diagnostics, Visgeneer has expanded into the cosmeceutical market, leveraging its research capabilities to develop high-end skincare products. The company is publicly traded on the Taiwan Emerging Stock Market and maintains a strong focus on R&D and international distribution of its diagnostic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Visgeneer Group.